Publications by authors named "Nathan D Seligson"

Claim this Profile
R
Revumenib for Relapsed or Refractory Acute Leukemia With a Translocation.
Emilie J Lynch, Sarah Jane E Faro, Alec M Lindstrom, Nadia A Sethi, Wendy Y Wang, Nathan D Seligson

Ann Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic mRNA vaccines elicit rapid immune activation in canine brain tumors.
Sheila Carrera-Justiz, Mahya Aghaee, Sadeem Qdaisat, Frances Weidert, Gabriel A Garcia, Nathan D Seligson

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From bench to bedside: a spotlight on pharmacogenomics at Nemours Children's Health.
Kelsey J Cook, Nathan D Seligson, Benjamin Q Duong, Vicky L Funanage, Susan M Kirwin

Pharmacogenomics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences for implementing pharmacogenomics in pediatric primary care: a discrete choice experiment.
Benjamin Q Duong, Nathan D Seligson, Kelsey J Cook, Lauren Lemke, Pamela Arn

Pediatr Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas.
Nathan D Seligson, Anjali Paragji, Feha Shahalam, Binyam Yilma, James L Chen

NPJ Precis Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes.
Alex Soupir, Oscar E Ospina, Oliver Hampton, Michelle Churchman, Michael Radmacher, Nathan D Seligson

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting CDKN2A dysregulation in Ewing sarcoma.
Anjali Paragji, Vivek Shastri, Elham Nasri, John A Ligon, Leighton A Elliott, Nathan D Seligson

Mol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities for Pharmacogenomics in Pediatrics: Prescribing Trends of Psychiatric Medications With Pharmacogenomic Implications at a Multistate Pediatric Health System.
Megan L Miller, Nathan D Seligson, Benjamin Q Duong, Josephine Elia, Shirin Hasan

J Pediatr Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas.
Nathan D Seligson, Yan W Asmann, Tariq Almerey, Yaquelin Coll Zayas, Mark A Edgar

Surg Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Nelson et al. Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. 2021, , 1566.
Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, Estrella Carballido, Alex Del Cueto

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses.
Nathan D Seligson, James L Chen, Austin C Goodrich, Brian A Van Tine, Jordan D Campbell

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab as the First Systemic Therapy Approved for Alveolar Soft Part Sarcoma.
Emilie J Bergsma, Mariam Elgawly, David Mancuso, Roger Orr, Theresa Vuskovich, Nathan D Seligson

Ann Pharmacother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation.
Nathan D Seligson, Xunjie Zhang, Mark C Zemanek, Jasmine A Johnson, Zachary VanGundy

Front Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene partners of the EWSR1 fusion may represent molecularly distinct entities.
Victoria Walker, Dexter X Jin, Sherri Z Millis, Elham Nasri, Diana A Corao-Uribe, Nathan D Seligson

Transl Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and as prognostic biomarkers for multiple myeloma in autologous stem cell transplant.
Melissa Thomas, Junan Li, Kevan King, Avinash K Persaud, Ernest Duah, Nathan D Seligson

Haematologica· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas.
Ernest Duah, Nathan D Seligson, Avinash K Persaud, Quynh Dam, Navjot Pabla

Mol Carcinog· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution.
Kelsey J Cook, Victoria Grusauskas, Lucy Gloe, Benjamin Q Duong, Renee C Gresh, Nathan D Seligson

Clin Transl Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer.
Nathan D Seligson, Jill M Kolesar, Benish Alam, Laura Baker, Jatinder K Lamba

Pharmacogenomics· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib Versus Dabrafenib + Trametinib in -Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial.
Naifa L Busaidy, Bhavana Konda, Lai Wei, Lori J Wirth, Catherine Devine, Nathan D Seligson

Thyroid· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas.
Nathan D Seligson, Joy Tang, Dexter X Jin, Monica P Bennett, Julia A Elvin

NPJ Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Campus-Wide Community Service Initiative during a Pandemic.
Kevan King, Hannah E Davis, Robin Moorman-Li, Kelsey J Cook, Nathan D Seligson

Pharmacy (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges.
Jocelyn Y Hsu, Nathan D Seligson, John L Hays, Wayne O Miles, James L Chen

JCO Precis Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key Considerations for Selecting a Genomic Decision Support Platform for Implementing Pharmacogenomics.
Kelsey J Cook, Benjamin Q Duong, Nathan D Seligson, Pamela Arn, Vicky L Funanage

Clin Pharmacol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.
Nathan D Seligson, Richard D Maradiaga, Colin M Stets, Howard M Katzenstein, Sherri Z Millis

NPJ Precis Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation.
Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, Estrella Carballido, Alex Del Cueto

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis